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a  b  s  t  r  a  c  t
In the  course  of  our ongoing  effort  to  identify  bioactive  compounds  from  marine-derived  fungi,  the
marine  fungus,  Penicillium  species  was  isolated  from  the Red  Sea  tunicate,  Didemnum  species.  Two  new
cerebrosides,  penicillosides  A  and  B  were  isolated  from  the marine-derived  fungus,  Penicillium  species
using  different  chromatographic  methods.  Their  structures  were  established  by  different  spectroscopic
1 13eywords:
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enicillosides
data  including  1D ( H  NMR  and C  NMR)  and 2D  NMR  (COSY,  HSQC,  and  HMBC)  studies  as  well  as  high-
resolution  mass  spectral  data.  Penicilloside  A displayed  antifungal  activity  against  Candida  albicans  while
penicilloside  B illustrated  antibacterial  activities  against  Staphylococcus  aureus  and  Escherichia  coli  in the
agar diffusion  assay.  Additionally,  both  compounds  showed  weak  activity  against  HeLa  cells.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.
ntimicrobial activity
eLa cells
ntroduction
Marine microorganisms have received a great attention lately;
ccordingly, the fungi began to be recognized as a liable source
f potentially useful natural products (Fenical, 1993; Bugni and
reland, 2004). Although studies on these organisms began much
ater than their counterparts in terrestrial environments, more
han a hundred novel compounds have been found annually since
he late 1990s (Blunt et al., 2013). The high number of com-
ounds reported from the genus Penicillium could be justiﬁed by
he fact that its different species are salt tolerant, fast growing and
re obtained easily from many substrates. This prompted many
esearchers to investigate variable Penicillium species isolated
rom different habitats. Their extensive studies concerned with
iological activities of the isolated secondary metabolites were
xtremely efﬁcient. Among the signiﬁcant activities reported were
he antibacterial (Qi et al., 2009; Devi et al., 2012; Abo-Kadoum
t al., 2013; Subramani et al., 2013), cytotoxic and anticancer (Wang
t al., 2009a,b; Sun et al., 2012; Gao et al., 2013; Abo-Kadoum et al.,
013; Subramani et al., 2013).In the course of our ongoing search for bioactive compounds
rom Red Sea marine-derived fungi, the fungus Penicillium species
as isolated from the tunicate Didemnum species and was cultured
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E-mail: dyoussef@kau.edu.sa (D.T.A. Youssef).
http://dx.doi.org/10.1016/j.bjp.2015.09.007
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorain Sabouraud dextrose broth. Fungal mycelia were extracted and
fractionated using different chromatographic techniques to afford
two compounds. Based on different spectroscopic data including
HRESIMS, 1D (1H NMR  and 13C NMR) and 2D NMR (COSY, HSQC,
and HMBC), the structures of the compounds were established as
cerebrosides and named penicillosides A (1) and B (2). The iso-
lated compounds were evaluated for their antimicrobial activities
against different pathogens and their cytotoxic activity against
HeLa cells. Penicillosides A and B displayed signiﬁcant antimicro-
bial activities against Candida albicans; Staphylococcus aureus and
Escherichia coli respectively in the agar diffusion assay. Additionally,
both compounds showed weak activity against HeLa cells.
Materials and methods
General experimental procedures
Optical rotation was measured on a JASCO digital Polarimeter.
1D and 2D NMR  spectra (chemical shifts in ppm, coupling constants
in Hz) were recorded on Bruker Avance DRX 600 MHz  spectrome-
ters using CD3OD as solvents. Normal and HRESIMS spectra were
recorded on a LTQ Orbitrap and an API 2000 (ThermoFinnigan, Bre-
men, Germany) mass spectrometers. For column chromatography,
silica gel (Merck, 70–230 mesh ASTM) and Sephadex LH-20 (Phar-
macia) were used. Pre-coated silica gel 60 F-254 plates (Merck)
were used for TLC. The HPLC separation was performed on a
RP18, 250 mm × 10 mm,  5 m Phenomenex Luna column using
 Ltda. All rights reserved.
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H3CN/H2O gradient as mobile phase at 220 nm and at a ﬂow rate
f 2.0 ml/min.
ollection of the host tunicate and preparation of the fungal isolate
The marine tunicate Didemnum species was collected in the
angrove located in Sharm El-Sheikh on the Egyptian Red Sea
oast at depth of 1–2 m during July 2010. In order to ensure fun-
al isolates to be endophytic when obtained, a surface sterilization
f tunicate was performed. The tunicate sample was disinfected
ith 5% sodium hypochlorite, followed by 70% ethanol (Li and
ang, 2009), to ensure that epiphytic fungi were destroyed by the
ashing while associated fungi (if any) were not affected. Approxi-
ately 2 cm3 of inner tissue of tunicate material was homogenized
sing a sterile mortar and pestle containing 10 ml  of sterile artiﬁ-
ial sea water under aseptic conditions. The resulting homogenate
as diluted with sterile seawater at three dilutions (1:10, 1:100,
nd 1:1000). For fungi cultivation, 100 l of each dilution was
lated in quadruplicate onto four plates of each of the follow-
ng media; Czapek-Dox yeast agar medium (NaNO3 3 g, KCl 0.5 g,
2HPO4 0.1 g, MgSO4·7H2O 0.5 g, FeSO4 0.01 g, sucrose 30 g, agar
0 g, pH 6.7); malt agar medium (malt extract 17 g, peptone 3 g,
gar 20 g) and Sabouraud dextrose agar medium. All media were
mended with 2% NaCl and 0.25% chloramphenicol as antibacterial
gent to prevent bacterial growth and to enrich fungi growth. Plates
ere wrapped in paraﬁlm, incubated at 28 ◦C for 1–3 weeks until
he morphology of fungi could be distinguished. Many puriﬁcation
teps were done until pure fungal isolates were obtained.
dentiﬁcation of fungal strain
xtraction of genome DNA from cultured fungal isolate
The fungal isolate was cultured in corresponding broth at 28 ◦C
or 2–5 days. The mycelia were harvested separately by using
acuum ﬁltration and dried with two layers of paper towel. The
esulting mycelial mat  was ground into powder with liquid nitro-
en. The fungal DNA was extracted using QIAamp DNA Mini Kit
Qiagen) according to manufacturer’s instructions.
mpliﬁcation of fungal ITS-rDNA fragments of isolate
The genomic DNA of the fungal strain was  used as
he template to amplify fungal ITS-rDNA fragments using
he primers ITS1 (5′-TCCGTAGGTGAACCTGCG-3′) and ITS4 (5′-
CCTCCGCTTATTGATATGC-3′) (White et al., 1990) which were
ynthesized by the University of Utah DNA/peptide synthesis core
acility. The reaction mixture for PCR ampliﬁcation contained 5 l of
0× reaction buffer with 15 mM MgCl2 (Invitrogen), 2 l of 2.5 mM
NTPs, 0.5 l of 10 M each primer, 4 l of fungal DNA, 0.3 l of
aq DNA polymerase (5 U l−1, Invitrogen), and 39.7 l of H2O. PCR
onditions included an initial denaturation at 94 ◦C for 4 min  fol-
owed by 30 cycles of denaturation at 94 ◦C for 50 s, annealing at
1 ◦C for 50 s, and elongation at 68 ◦C for 1 min, with a ﬁnal elon-
ation at 68 ◦C for 10 min. PCR products were puriﬁed using the
garose Gel DNA Puriﬁcation Kit (Qiagen) and sequenced in at the
niversity of Utah DNA sequencing facility.
equence fungal ITS-rDNA regions of isolate
For preliminary identiﬁcation, sequences of fungal ITS-rDNA
egions obtained from the marine tunicate Didemnum species were
ompared with related sequences in National Center for Biotech-
ology Information (NCBI) (http://www.ncbi.nlm.nih.gov). Fungal
TS-rDNA sequences acquired in this study were edited and aligned
ith the best n-BLAST hits from GenBank in the Clustal X (ver-
ion 1.83) program (Thompson et al., 1997), and further manually
djusted using BioEdit software (Hall, 1999). The program MEGA Farmacognosia 26 (2016) 29–33
5 (Tamura et al., 2011) was applied to calculate the base composi-
tion of the fungal sequences. The sequence analysis based on 99%
sequence identity with Penicillium species Rsf-2 (NCBI accession
number EF660439.1).
Isolation and puriﬁcation of compounds 1 and 2
Large scale culture of the marine-derived fungus Penicillium
species was carried out. The culture was incubated at room tem-
perature for 30 days. After that, 250 ml  of EtOAc were added to
each ﬂask left overnight to stop cell growth. Culture media and
mycelia were separated by vacuum ﬁltration using Buchner funnel.
The mycelia were left in MeOH overnight for extraction. The extract
was dried under reduced pressure. The viscous extract (1200 mg)
was dissolved in 250 ml  of 70% MeOH then extracted with hex-
ane (3 ml  × 100 ml). The methanol layer was  concentrated under
reduced pressure to yield another viscous brown residue (765 mg).
A portion of the alcoholic extract (600 mg)  was fractionated over
silica gel (Vaccum Liquid Chromatography) using CHCl3/MeOH gra-
dient (100% CHCl3 then 2, 5, 7, 10, 15% MeOH in CHCl3) to give six
main fractions. Fraction 2 (65 mg,  eluted with 2% MeOH in CHCl3)
was puriﬁed on Sephadex LH-20, eluted with MeOH to obtain ﬁnally
ten sub-fractions. Final puriﬁcation of the main subfractions was
achieved by HPLC using gradient system started with 5% ACN/H2O
to 100% ACN in 15 min  to afford compound 1 (3 mg). Fraction 3
(145 mg)  was  dissolved in MeOH and subjected to Sephadex LH-
20column eluted with 100% MeOH. The fractions showing distinct
spots were puriﬁed on silica gel using pet. ether/CHCl3/MeOH gra-
dient (100% pet. Ether, followed by 20, 40, 60, 80% CHCl3 in pet.
Ether, followed by 5, 10, 15, 20% MeOH in CHCl3). Fractions eluted
with 5% MeOH in CHCl3 offered impure 2. Final puriﬁcation was
performed by HPLC using gradient system from 10% ACN/H2O to
100% ACN over 20 min  to obtain compound 2 (23.1 mg).
Biological evaluation of compounds 1 and 2
Determination of the antimicrobial activity of compounds 1 and 2
The procedure was conducted in triplicate according to Valgas
et al. (2007) and Singh and Jain (2011). Compounds 1 and 2 were
tested for antibacterial activity against a Gram positive bacterium
(Staphylococcus aureus ATCC 25923), a Gram negative bacterium
(Escherichia coli ATCC 25922), and yeast (Candida albicans ATCC
14053) using agar diffusion method. Accurately measured 0.1 ml
(100 g dissolved in DMSO) of each compound were inserted in
the cups then incubated at 37 ◦C for 24 h. The inhibition zones
were measured and compared with the reference antibiotics and
antifungal drugs; ampicillin, imipenem and clotrimazole (each of
10 g/disc giving 30, 30 and 40 mm inhibition zone respectively).
Determination of cytotoxic activity of compounds 1 and 2
The effects of compounds 1 and 2 on HeLa cell proliferation and
cytotoxicity were evaluated using the sulforhodamine B (SRB) assay
(Boyd et al., 1995; Skehan et al., 1990). HeLa cells were grown in
Basal Medium Eagle (BME) containing Earle’s salts, 10% FBS and
50 g/ml gentamycin sulfate. Cells were plated at a density of 2500
cells per well in a 96-well plate and allowed to adhere and grow
for 24 h before compounds were added. The compounds were sol-
ubilized in DMSO and added to a ﬁnal DMSO concentration of 1% in
both test wells and vehicle controls. The cells were incubated with
compounds or vehicle for an additional 48 h. The IC50, the concen-
trations required to cause a 50% inhibition of cell proliferation, weresent the average of 3–4 independent experiments, each conducted
in triplicate ± SEM. Cytotoxicity was  determined by a cell density
lower than that measured at the time of drug addition. Paclitaxel
was used as a positive control.
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Table  1
NMR  spectral data of compounds 1 and 2 (CD3OD).
Position 1 2
ıC (mult.)a ıH (mult., J in Hz) ıC (mult.)a ıH (mult., J in Hz)
1 67.4 (CH2) 3.63 (m)  69.7 (CH2) 4.11, m; 3.7, dd (10.2, 3.6)
2  54.6 (CH) 3.97 (m)  54.6 (CH) 3.97, m
3  71.5 (CH) 3.64 (m) 35.9 (CH2) 1.69, m; 1.5 m
4  33.1 (CH2) 2.04 (m)  26.1 (CH2) 1.39, m
5  32.7 (CH2) 1.28 (m)  40.8 (CH2) 1.97, t (7.2)
6  26.5 (CH2) 2.78 (brt, 6.0) 136.8 (q C) –
7  131.0 (CH) 5.34 (brd, 14.1) 124.8 (CH) 5.14, t (6.6)
8  130.8 (CH) 5.32 (m)  33.8 (CH2) 2.07, m
9  28.2 (CH2) 2.05 (m) 33.1 (CH2) 1.28, m
10  14.5 (CH3) 0.89, t (6.6)
11  16.1 (CH3) 1.59, s
10–14  29.1–30.8 (5× CH2) 1.24–1.33 (m)
15  23.7 (CH2) 1.24–1.33 (m)
16  14.4 (CH3) 0.90 (t, 6.6)
1′ 174.2 (q C) – 177.2 (q C) –
2′ 72.95 (CH) 4.16 (m)  72.9 (CH) 4.12, d (6.6)
3′ 35.0 (CH2) 2.33 (m)  73.1 (CH) 3.98, dd (7.8, 4.2)
4′ 26.05 (CH2) 1.60 (m)  131.1 (CH) 5.47, dd (15.6, 7.8)
5′ 29.2 (CH2) 2.22 (m) 134.6 (CH) 5.71, m
6′ 130.7 (CH) 5.38 (m)
7′ 130.9 (CH) 5.42 (brd, 15.0)
8′ 29.1 (CH2) 2.06 (m)
9′ 26.5 (CH2) 2.68 (m)
10′ 129.0 (CH) 5.31 (m)
6′-10′ 30.5–33.0 (5×  CH2) 1.25–1.35, m
11′ 129.1 (CH) 5.29 (brd, 13.2) 14.4 (CH3) 0.89, t (6.6)
12′ 28.1 (CH2) 2.05 (m)
13′-16′ 29.1–30.8 (4× CH2) 1.24–1.33 (m)
17′ 23.6 (CH2) 1.24–1.33 (m)
18′ 14.4 (CH3) 0.90 (t, 6.6)
1′′ 104.7 (CH) 4.26 (d, 7.2) 104.7 (CH) 4.27, d (7.8)
2′′ 75.0 (CH) 3.18 (m)  75.0 (CH) 3.18, m
3′′ 77.9 (CH) 3.34 (m)  77.9 (CH) 3.34, m
4′′ 71.8 (CH) 3.27 (m)  71.5 (CH) 3.27, m
5′′ 78.0 (CH) 3.28 (m)  78.0 (CH) 3.28, m
6′′ 62.6 (CH2) 3.86 (m), 3.67 (m)  62.6 (CH2) 3.85, dd (12.0, 1.2);
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Aa Multiplicity was  detected from HSQC.
pectral data
Penicilloside A (1). Colourless amorphous powder, positive
RESIMS m/z 712.5366 (calculated for C40H74NO9, 712.5364
M+H]+), []D −13◦ (c 1.5, MeOH). NMR  data: see Table 1.
Penicilloside B (2). Colourless amorphous powder; positive
RESIMS m/z 546.3646 (calculated for C28H52NO9, 546.3642
M+H]+), []D −19.6◦ (c 1.5, MeOH). NMR  data: see Table 1.
esults and discussion
Compound 1 was isolated as a colourless amorphous pow-
er. Its molecular formula was suggested as C40H73NO9 based
n different spectral data including HRESIMS (m/z 712.5366,
M+H]+), 1D and 2D NMR  data (Table 1). Different spectral data
eclared the presence for a sugar moiety, an amide linkage and
liphatic chains, thus supporting its cerebroside nature (Wang
t al., 2009a,b). Analysis of 1H NMR  and 13C NMR  data proved the
resence of signals of glucose moiety, where 1H NMR  spectrum
evealed signals resonating in the range of 3.18–4.26 ppm. HSQC
orrelated these protons to their corresponding carbons detected
n the range of 62.6–104.7 ppm. The coupling constant of the
nomeric proton (J = 7.2 Hz) conﬁrmed the ˇ-conﬁguration of the
lucose moiety (Ren et al., 2009; She et al., 2009; Peng et al.,
011). Careful examination of different spectral data allowed the
ssignment of two subunits; subunit A (C-1 → C-16) and subunit
 (C-1′ → C18′). From the COSY and HSQC experiments, subunit
 was assigned as one methyl, one oxygenated methylene, two3.66, dd (11.4, 4.8)
downﬁeld shifted methines, two protonated sp2 carbons and
ten methylenes. From 2D NMR  spectra, C-3 was proved to be
oxygenated as established from the chemical shift at ıC 71.5/ıH
3.64. The other methine was conﬁrmed to be linked to the amide
group, the hydroxylated methine (C-3) and the oxygenated methy-
lene (ıC 67.4/ıH 3.63). Thus, the fragement from C-1 to C-3 was
proved. The location of the sp2 carbons was suggested to be at
C-7/C-8 separated from C-3 by three methylenes. This suggestion
was conﬁrmed from spin–spin coupling between H-7 (ı 5.34)
and H2-6 (ı 2.78) which in turn was coupled with H2-5 (ı 1.28).
Also H2-4 (ı 2.04) was  coupled with H-3 (ı 3.64). Additionally,
HMBC revealed cross peaks from H2-9 (ı 2.05) to C-8 (ı 130.8)
and to C-7 (ı 131.0), conﬁrming the assignment of the fragment
C-1 to C-8. The last part of subunit (A) was found to consist of a
terminal methyl (ıC 14.4/ıH 0.90) which was  coupled to C-15; the
adjacent methylene. H-8 revealed spin–spin coupling with C-9
(the adjacent methylene). The number of the methylene groups
between C-8 and the terminal methyl C-16 was  found to be seven
as indicated from MS  spectrum, through the fragment detected
at m/z 599 corresponding to a loss of the terminal methyl in
addition to seven methylenes. Accordingly, subunit A (C-1 to C-16)
structure was conﬁrmed. The chemical shift values of H2-1, H-2,
H-3 together with their corresponding carbons are comparable
to those previously reported for similar cerebrosides (Peng et al.,
2011). Subunit B was proved to consist of eighteen carbons (C-1′
to C-18′). HMBC declared cross peaks from each of H-2′ (ı 4.16),
H2-3′ (ı 2.33) and H2-4′ (ı 1.60) to C-1′ (ı 174.2). Therfore, the
assignment of the fragment C-1′ to C-4′ was conﬁrmed. Four
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Fig. 1. Selected COSY and HMBC correlations of compounds 1 and 2.
rotonated sp2 carbons were detected in fragment B. Their loca-
ion was deﬁned at C-6′/C-7′ and C-10′/C-11′. The non interrupted
pin–spin coupling from H2-3′ to H-6′ and from H-7′ to H-10′
upported this assumption. A further conﬁrmation was gained
rom HMBC which revealed cross peaks from H2-8′ (ı 2.06) to each
f C-6′ (ı 130.7) and C-7′ (ı 130.9) and from H2-9′ (ı 2.68) to each
f C-10′ (ı 129.0) and C-11′ (ı 129.1). The terminal methyl group
CH3-18) was linked to H2-17′ and C-17′ as declared from COSY
nd HMBC respectively (Fig. 1). The 1H and 13C NMR  data for C-1′,
-2′ and H-2′ are typical for those previously reported for similar
erebrosides (Elkhayat et al., 2012). The connection of subunit A
ith B was conﬁrmed from HMBC that showed cross peaks from
-3 to C-1′. Additional cross peak from H-1′′ to C-1 conﬁrmed the
ttachment of subunit A with the glucose moiety. Based on the pre-
ious discussion, the structure of compound 1 was established. This
s the ﬁrst report of this compound from natural source. Therefore,
t is considered as a new natural product and named penicilloside A.
HO
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Compound 2 was isolated as a colourless amorphous powder.
ts molecular formula was  suggested as C28H51O9N based on dif-
erent spectral data including HRESIMS (m/z 546.3646 [M+H]+), 1H
MR, 13C NMR  and HSQC (Table 1). The cerebroside nature of com-
ound 2 was suggested from 1D NMR  data which declared the
resence of a sugar residue, one or more aliphatic chains and an
mide linkage (Elkhayat et al., 2012). Analysis of 1H–1H COSY spec-
rum (Fig. 1) led to the identiﬁcation of subunit A (C-1 → C-10) and Farmacognosia 26 (2016) 29–33
subunit B (C-2′ → C-11′). Careful investigation of different spectral
data declared the presence of 2 sp2 carbons including a trisubsti-
tuted oleﬁnic moiety in the subunit A. This was  proved from the
carbon signals resonating at ı 136.8 (qC) and 124.8 (CH). The latter
carbon was connected to the proton at ıH 5.14. The signal resonat-
ing at ı 136.8 was attributed to quaternary carbon as predicted from
HSQC experiment. HMBC experiment (Fig. 1) revealed a cross peak
from H3-11 (ı 1.59) to the quaternary sp2 carbon (ı 136.8) beside
the other sp2 carbon and C-5 (ı 40.8). This supported the location of
the H3-11 (ıH 1.59/ıC 16.1) as being directly linked to the oleﬁnic
carbon (ı 136.8). Both COSY and HMBC data conﬁrmed the location
of the double bond at C-6/C-7 and also proved the whole structure
of subunit A (C-1 to C-10). Investigation of the different NMR  data
(1H NMR, 13C NMR, COSY, HSQC and HMBC) proved the incorpo-
ration of a double bond and two  hydroxylated methines within
subunit B. The COSY spectrum declared the spin–spin coupling
between the protons resonating at ı 3.98 (H-3′) and 4.12 (H-2′)
which are linked to the carbons at ı 73.1 (C-3′) and 72.9 (C-2′)
respectively. This supported the location of the two hydroxyls at C-
2′ and C-3′. The HMBC demonstrated a cross peak from the proton
resonating at ı 3.98 (H-3′) to the amidic carbonyl at ı 177.2 (C-1′)
and conﬁrming the assignment of the substructure C-1′ to C-3′. The
presence of a double bond at C-4′/C-5′ was conﬁrmed from the pro-
ton signals at ı 5.47 (H-4′) and 5.71 (H-5′) which correlated to the
signals at ı 131.1 and 134.6 respectively in the HSQC spectrum. The
HMBC showed cross peaks from H-3′ (ı 3.98) to C-4′ (ı 131.1) and
hence supporting the presence of oleﬁnic moiety at C-4′/C-5′.
The large coupling constant between H-4′ and H-5′ (J = 15.6 Hz)
was consistent with E conﬁguration (Yoshikawa et al., 1996; Wang
et al., 2009a,b). As declared from COSY and HMBC data (Fig. 1),
the structure of subunit B (C-1′ to C-11′) was conﬁrmed. The pres-
ence of a glucose moiety was  conﬁrmed from the signals resonating
between 62.6 and 104.7 ppm in 13C NMR  spectrum along with their
corresponding proton signals detected between 3.18–4.18 ppm in
1H NMR  spectrum. The link between each proton and its corre-
sponding carbon was proved from HSQC. The large value of the
coupling constant (J = 7.8 Hz) of the anomeric proton (H-1′′, ı 4.27)
conﬁrmed its ˇ-conﬁguration (Peng et al., 2011; Ren et al., 2009;
She et al., 2009). The attachment of the glucose moiety to the sub-
unit A was  conﬁrmed from the HMBC cross-peaks of H-1/C-1′′.
Based on the previous discussion, the structure of compound 2 was
conﬁrmed. It is reorted here for the ﬁrst time from natural source
and was  given the generic name penicilloside B.
The antimicrobial activity of compounds 1 and 2 was evaluated
by determining the growth inhibition zone. Compound 1 revealed
antifungal activity towards C. albicans as it showed inhibition zone
of 23 mm.  Additionally, compound 2 was active against S. aureus
with 19 mm inhibition zone and E. coli (20 mm). On the other hand,
Both compounds showed weak activity with IC50 ≥50 g/ml when
tested against HeLa cells.
Conclusion
Investigation of the marine-derived fungus Penicillium species
yielded two  new cerebrosides, penicillosides A and B (1 and 2).
Compound 1 revealed antifungal activity towards C. albicans. Addi-
tionally, compound 2 showed antibacterial activity against S. aureus
and E. coli. On the other hand, Both compounds showed weak activ-
ity with IC50 ≥50 g/ml when tested against HeLa cells.Authors’ contribution
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